Objective
Study Design
Results
Conclusion
Key words
Methods
Study design
Outcomes
Statistical analysis
Results
Characteristic | n (%) |
---|---|
MATERNAL | |
Age, y | |
<20 | 10,187 (8.8) |
20-24.9 | 24,299 (21.0) |
25-29.9 | 31,101 (26.9) |
30-34.9 | 30,570 (26.5) |
≥35 | 19,345 (16.8) |
Race/ethnicity | |
Non-Hispanic white | 52,040 (45.1) |
Non-Hispanic black | 23,878 (20.7) |
Non-Hispanic Asian | 5999 (5.2) |
Hispanic | 27,291 (23.6) |
Other | 5083 (4.4) |
Not documented | 1211 (1.1) |
Body mass index at delivery, kg/m2 | |
<25 | 14,242 (12.6) |
25-29.9 | 41,268 (36.5) |
30-34.9 | 32,088 (28.4) |
35-39.9 | 15,088 (13.3) |
≥40 | 10,481 (9.3) |
Cigarette use during pregnancy | 11,370 (9.9) |
Cocaine or methamphetamine use during pregnancy | 830 (0.7) |
Insurance status | |
Uninsured/self-pay | 11,989 (10.5) |
Government-assisted | 45,125 (39.4) |
Private | 57,462 (50.2) |
Prenatal care | 107,510 (97.9) |
Obstetric history | |
Nulliparous | 46,773 (40.5) |
Previous vaginal delivery only | 49,865 (43.2) |
Previous cesarean delivery only | 8872 (7.7) |
Previous cesarean and vaginal deliveries | 9963 (8.6) |
Any hypertension | 13,272 (11.5) |
Diabetes mellitus | |
None | 106,706 (92.4) |
Gestational | 6999 (6.1) |
Pregestational | 1734 (1.5) |
Anticoagulant use during pregnancy | 920 (0.8) |
Multiple gestation | 2815 (2.4) |
Polyhydramnios | 940 (0.8) |
Oligohydramnios | 4700 (4.1) |
Placenta previa | 467 (0.4) |
Placenta accreta | 158 (0.1) |
Placental abruption | 930 (0.8) |
Premature rupture of membranes/preterm premature rupture of membranes | 6004 (5.3) |
Group B Streptococcus status | |
Negative | 68,918 (59.7) |
Positive | 24,390 (21.1) |
Unknown | 22,194 (19.2) |
NEONATAL | |
Presentation at delivery | |
Vertex | 111,174 (94.1) |
Breech | 6010 (5.1) |
Nonbreech malpresentation | 931 (0.8) |
Gestational age at delivery, wk | |
230-276 | 1256 (1.1) |
280-336 | 4282 (3.6) |
340-366 | 10,024 (8.5) |
370-376 | 10,914 (9.2) |
380-386 | 20,723 (17.5) |
390-396 | 37,695 (31.8) |
400-406 | 23,876 (20.2) |
410-416 | 8998 (7.6) |
≥420 | 654 (0.6) |
Birthweight, g | |
<2500 | 12,498 (10.6) |
2500-3999 | 96,708 (81.7) |
≥4000 | 9186 (7.8) |
Size for gestational age | |
Small | 11,530 (9.7) |
Appropriate | 97,774 (82.6) |
Large | 9088 (7.7) |
Characteristics | n (%) |
---|---|
Specialty of attending at delivery | |
General obstetrics and gynecology | 84,057 (72.8) |
Midwife | 7808 (6.8) |
Family medicine | 3728 (3.2) |
Maternal-fetal medicine | 18,954 (16.4) |
No attending at delivery | 859 (0.7) |
Years since attending at delivery graduated medical or midwifery school | |
0-9.9 (includes no attending at delivery) | 26,717 (23.4) |
10-14.9 | 21,793 (19.1) |
15-20.9 | 19,880 (17.4) |
20-24.9 | 16,248 (14.2) |
≥25 | 29,428 (25.8) |
Nurse-to-patient ratio at delivery | |
<1 | 31,781 (27.6) |
1-1.9 | 58,263 (50.7) |
2-2.9 | 15,804 (13.7) |
≥3 | 9160 (8.0) |
Patient delivered at hospital where prenatal electronic medical record available | |
No | 47,727 (41.3) |
Sometimes | 35,083 (30.4) |
Yes | 32,692 (28.3) |
Patient delivered at hospital with 24-hour in-house obstetric anesthesia service | |
No | 13,150 (11.4) |
Yes | 102,352 (88.6) |
Patient delivered at hospital with 24-hour in-house attending obstetric provider | |
No | 13,823 (12.0) |
Yes | 101,679 (88.0) |
Patient delivered at hospital with attending providers and/or nurses present for structured obstetric patient review | |
No obstetricians present at review | 21,106 (18.3) |
Obstetricians but no nurses present at review | 38,052 (32.9) |
Both obstetricians and nurses present at review | 56,344 (48.8) |
Patient delivered at hospital with 24-hour in-house interventional radiology available | |
No | 79,452 (68.8) |
Yes | 36,050 (31.2) |
Patient delivered at hospital with 24-hour in-house attending neonatologist or pediatrician | |
No neonatologist, no pediatrician | 12,532 (10.9) |
Pediatrician, no neonatologist | 4363 (3.8) |
Neonatologist | 98,314 (85.3) |
Variable | Lowest % | Median % | Highest % |
---|---|---|---|
Labor induction | 20.8 | 28.2 | 37.1 |
Dilation ≤2 cm at admission | 6.6 | 13.6 | 25.9 |
Maximum oxytocin ≥20 mU/min | 8.7 | 17.6 | 46.3 |
≥80% of labor augmented with oxytocin | 1.0 | 10.1 | 22.6 |
≥1 hr between complete dilation and initiation of pushing | 0.8 | 10.9 | 21.2 |
≥2 hr between initiation of pushing to delivery | 4.4 | 9.1 | 19.2 |
≥8 hr active phase | 2.9 | 8.3 | 19.2 |
<1 vaginal examination per every 3 hr in first stage | 2.9 | 21.0 | 43.7 |
Vaginal delivery | 60.6 | 70.1 | 79.5 |
Episiotomy | 0.7 | 7.0 | 35.4 |
Epidural/regional anesthesia | 45.3 | 77.7 | 89.7 |
General anesthesia | 1.1 | 6.5 | 14.8 |
Elective delivery at <39 weeks' gestation without documented fetal lung maturity | 0.2 | 0.5 | 12.2 |
Process measure | Postpartum hemorrhage | Peripartum infection b Adjusted for age, body mass index, cigarette use, insurance status, obstetric history, diabetes mellitus, premature rupture of membranes/preterm premature rupture of membranes, group B Streptococcus status, gestational age at delivery, attending specialty, years since attending graduated medical or midwifery school, nurse-to-patient ratio, prenatal electronic medical record present, attending providers and/or nurses present for structured obstetric patient review, hospital volume | Severe perineal laceration at spontaneous vaginal delivery, | Severe perineal laceration at forceps-assisted vaginal delivery, | Severe perineal laceration at vacuum-assisted vaginal delivery, | Composite neonatal adverse outcome, g Adjusted for body mass index, cigarette use, cocaine or methamphetamine use, insurance status, prenatal care, obstetric history, any hypertension, diabetes mellitus, premature rupture of membranes/preterm premature rupture of membranes, size for gestational age, attending specialty, round-the-clock in-house attending pediatrician available. |
---|---|---|---|---|---|---|
n | 105,987 | 110,205 | 68,144 | 1898 | 3515 | 89,279 |
Labor induction | 1.20 (1.04–1.37) | 1.22 (1.13–1.33) | 1.04 (0.90–1.21) | 1.05 (0.78–1.42) | 0.92 (0.70–1.21) | 1.18 (1.05–1.34) |
Dilation ≤2 cm at admission | 1.58 (1.37–1.82) | |||||
Maximum oxytocin ≥20 mU/min | 1.61 (1.33–1.95) | 1.30 (1.16–1.44) | ||||
≥80% of labor augmented with oxytocin | 1.08 (0.78–1.50) | 1.63 (1.42 –1.87) | ||||
≥1 hr between complete dilation and initiation of pushing | 1.67 (1.22–2.28) | 1.29 (1.04–1.59) | 1.10 (0.74–1.64) | 0.94 (0.65–1.34) | 1.13 (0.89–1.45) | |
≥2 hrs between initiation of pushing to delivery | 4.02 (3.10–5.23) | 1.88 (1.51– 2.34) | 1.21 (0.87–1.69) | 1.55 (1.15–2.09) | 1.83 (1.46–2.28) | |
≥8 hrs active stage | 1.32 (1.08–1.62) | |||||
<1 vaginal examination per every 3 hours in first stage | 1.18 (1.07–1.30) | 1.18 (1.01–1.38) | ||||
Vaginal delivery | 0.19 (0.16–0.22) | 0.52 (0.47–0.56) | 0.72 (0.63–0.83) | |||
Episiotomy | 1.22 (1.04–1.43) | 2.47 (2.08–2.93) | 1.24 (0.87–1.79) | 1.99 (1.51–2.62) | ||
Epidural/regional anesthesia | 0.88 (0.73–1.06) | (small no. precludes analysis) | 0.90 (0.57–1.45) | |||
General anesthesia | 3.61 (2.98–4.37) | |||||
Elective delivery at <39 wk gestation without documented fetal lung maturity | 1.39 (0.67–2.89) | |||||
Composite process measure exposure score (Percentage of care received that was associated with fewer adverse outcomes; referent received 100% of care eligible) | 0-67%: 4.69 (3.89–5.64) | 0-57%: 1.88 (1.68–2.11) | 0-67%: 2.18 (1.88–2.54) | N/A | 0-50%: 2.64 (1.96–3.55) | 0-67%: 1.65 (1.43–1.91) |
75-83%: 2.25 (1.79–2.83) | 60-86%: 1.89 (1.70–2.09) | 75-83%: 1.34 (1.16–1.56) |
Variable | Denominator size for each outcome, n | Crude hierarchical regression | Hierarchical regression with patient characteristics | Hierarchical regression with patient and provider/hospital characteristics | Hierarchical regression with patient, provider/hospital, and care characteristics |
---|---|---|---|---|---|
Postpartum hemorrhage | 105,987 | 0.20 (0.06) | 0.16 (0.05) | 0.13 (0.04) | 0.13 (0.04) |
Peripartum infection | 110,205 | 0.18 (0.05) | 0.21 (0.06) | 0.18 (0.06) | 0.18 (0.06) |
Severe perineal laceration at spontaneous vaginal delivery | 68,144 | 0.15 (0.05) | 0.09 (0.03) | 0.09 (0.03) | 0.09 (0.03) |
Severe perineal laceration at forceps-assisted vaginal delivery | 1898 | 0.33 (0.13) | 0.25 (0.11) | 0.26 (0.12) | N/A |
Severe perineal laceration at vacuum-assisted vaginal delivery | 3515 | 0.20 (0.09) | 0.15 (0.08) | 0.15 (0.08) | 0.14 (0.08) |
Composite neonatal adverse outcome | 89,279 | 0.17 (0.05) | 0.10 (0.04) | 0.09 (0.03) | 0.09 (0.03) |
Comment
Acknowledgments
Appendix






References
- Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma.Lancet. 2004; 363: 1147-1154
- Defining and measuring patient safety.Crit Care Clin. 2005; 21: 1-19
- Impact of risk-adjusting cesarean delivery rates when reporting hospital performance.JAMA. 1998; 279: 1968-1972
- Are the Agency for Healthcare Research and Quality obstetric trauma indicators valid measures of hospital safety?.Am J Obstet Gynecol. 2006; 195: 868-874
- Quality improvement demands quality measurement.BJOG. 2010; 117: 1571-1574
- Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals.Am J Obstet Gynecol. 2013; 209: 446.e1-446.e30
- Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and method.Int J Epidemiol. 2006; 35: 1292-1300
- A simple method of sample size calculation for linear and logistic regression.Stat Med. 1998; 17: 1623-1634
- Design of a clustered observational study to predict emergency admissions in the elderly: statistical reasoning in clinical practice.J Eval Clin Pract. 2007; 13: 169-178
- Neonatal intensive care unit characteristics affect the incidence of severe intraventricular hemorrhage.Med Care. 2006; 44: 754-759
Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-20.
Article Info
Publication History
Footnotes
Members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network appear in the Acknowledgments.
Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [ HD21410 , HD27869 , HD27915 , HD27917 , HD34116 , HD34208 , HD36801 , HD40500 , HD40512 , HD40544 , HD40545 , HD40560 , HD40485 , HD53097 , HD53118 ] and the National Center for Research Resources [ UL1 RR024989 ; 5UL1 RR025764 ] and its contents do not necessarily represent the official views of the NICHD, NCRR, or NIH.
The authors report no conflict of interest.
Cite this article as: Grobman WA, Bailit JL, Rice MM, et al. Can differences in obstetric outcomes be explained by differences in the care provided? The MFMU Network APEX study. Am J Obstet Gynecol 2014;211:147.e1-16.